Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Oct 10, 2014 (12 years ago)

Assured Naproxen Sodium Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Correct Labeled Product Mispacked; correct labeled bottles of Assured Ibuprofen softgels were packaged into cartons of Assured Naproxen Sodium Tablets, USP

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Assured Naproxen Sodium Tablets, USP 220 mg., 15 count bottle, Repackaged by Contract Packaging Resources, Inc 8009 Industrial Village Road Greensboro, NC 27409 Distributed by Greenbrier International, Inc Chesapeake, VA 23320

Drug: Naproxen Category: Pain Relief & OTC Medication

Recalling firm
Contract Packaging Resources Inc.
Origin
NC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0248-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Naproxen recalls

See all
Class II · Moderate risk

Naproxen Oral Suspension

Chemical contamination; presence of lead and lithium above specification

Ongoing Chemical / undeclared Acella Pharmaceuticals, LLC NDC 42192-619-16 D-0523-2026
Class II · Moderate risk

Naproxen Tablets

Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

Ongoing Labeling / mix-up Glenmark Pharmaceuticals Inc., USA NDC 68462-188-01 D-0124-2024

Other labeling / mix-up recalls from 2014

All labeling / mix-up recalls
Class III · Low risk

3M ESPE Clinpro 5000

Labeling: Incorrect or Missing Lot and/or Exp. Date - The subject lot is missing the lot number and expiration date stamp on the primary box..

Terminated Labeling / mix-up 3M Company/3m Espe Dental Products NDC 48878-3130-04 D-0376-2015
Class II · Moderate risk

J-TAN D PD Drops

Labeling: Not Elsewhere Classified: Product is labeled "Dye Free" on front panel but contains Red Dye 40.

Terminated Labeling / mix-up Jaymac Pharmaceuticals L.L.C. D-0327-2015
Class III · Low risk

BELVIQ¿ (Lorcaserin HCl)

Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.

Terminated Labeling / mix-up Eisai Inc D-0302-2015
Class III · Low risk

Fluoxetine Capsules USP

Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.

Terminated Labeling / mix-up Sandoz Incorporated NDC 0781-2822-01 D-0291-2015